Kang Cui

617 total citations
22 papers, 452 citations indexed

About

Kang Cui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kang Cui has authored 22 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Kang Cui's work include Cancer-related molecular mechanisms research (4 papers), Cancer Research and Treatments (3 papers) and RNA modifications and cancer (3 papers). Kang Cui is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer Research and Treatments (3 papers) and RNA modifications and cancer (3 papers). Kang Cui collaborates with scholars based in China, United States and Singapore. Kang Cui's co-authors include Wang Ma, Yabing Du, Hongyin Du, Debin Liu, Lei Chen, Liying Shi, Wenli Yu, Mingwei Sheng, Huan Zhao and Yurong Du and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Kang Cui

20 papers receiving 446 citations

Peers

Kang Cui
Hyuk-Jai Jang South Korea
Birdal Bilir United States
Yang Ke China
Ying Piao China
Kang Cui
Citations per year, relative to Kang Cui Kang Cui (= 1×) peers Jianguo Xie

Countries citing papers authored by Kang Cui

Since Specialization
Citations

This map shows the geographic impact of Kang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Cui more than expected).

Fields of papers citing papers by Kang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Cui. The network helps show where Kang Cui may publish in the future.

Co-authorship network of co-authors of Kang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Kang Cui. A scholar is included among the top collaborators of Kang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Cui. Kang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Kang, Yuanyuan Zheng, Zhibo Shen, et al.. (2025). Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA. Journal for ImmunoTherapy of Cancer. 13(9). e011831–e011831.
2.
Du, Yurong, Lei Liu, Yang Li, et al.. (2023). The anticancer mechanisms of exopolysaccharide from Weissella cibaria D-2 on colorectal cancer via apoptosis induction. Scientific Reports. 13(1). 21117–21117. 10 indexed citations
3.
Liu, Lei, Yurong Du, Yabing Du, et al.. (2023). Exopolysaccharide from Weissella confusa J4-1 inhibits colorectal cancer via induction of cell cycle arrest. International Journal of Biological Macromolecules. 253(Pt 8). 127625–127625. 5 indexed citations
4.
Cui, Kang, et al.. (2023). A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma. Frontiers in Oncology. 13. 1174788–1174788.
5.
Du, Yurong, Lei Liu, Yabing Du, et al.. (2023). The role of extratumoral and intratumoral microorganisms in cancer immunotherapy. 1(2). 100016–100016. 11 indexed citations
6.
Zhao, Huan, Yurong Du, Lei Liu, et al.. (2022). Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis. Journal of Materials Chemistry B. 10(21). 4002–4011. 34 indexed citations
7.
Zhu, Li, Kang Cui, Yabing Du, et al.. (2021). B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein. Frontiers in Oncology. 11. 722828–722828. 6 indexed citations
8.
Du, Yabing, Wang Ma, Peihao Wen, et al.. (2021). Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1. Pharmacological Research. 169. 105648–105648. 31 indexed citations
9.
Zhu, Li, Kang Cui, Yabing Du, et al.. (2021). A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells. PLoS ONE. 16(6). e0249174–e0249174. 11 indexed citations
10.
Guo, Jiacheng, Kang Cui, Yabing Du, et al.. (2020). Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production. Biomedicine & Pharmacotherapy. 131. 110740–110740. 9 indexed citations
11.
Wang, Yanyan, Kang Cui, Mingzhi Zhu, & Yuanting Gu. (2020). Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(8). 612–623. 3 indexed citations
12.
Huang, Liping, Kang Cui, Yurong Du, et al.. (2020). Weissella cibaria Attenuated LPS-Induced Dysfunction of Intestinal Epithelial Barrier in a Caco-2 Cell Monolayer Model. Frontiers in Microbiology. 11. 2039–2039. 36 indexed citations
13.
Cui, Kang, et al.. (2020). The microRNA cluster miR-30b/-30d prevents tumor cell switch from an epithelial to a mesenchymal-like phenotype in GBC. Molecular Therapy — Methods & Clinical Development. 20. 716–725. 2 indexed citations
14.
Cui, Kang, Yongjun Chen, Linfu Zhou, et al.. (2019). Generation of IgE-specific cytotoxic T lymphocytes as a novel immunotherapeutic approach for the treatment of allergic asthma. Singapore Medical Journal. 61(4). 212–220. 1 indexed citations
15.
Cui, Kang, Shuiling Jin, Yabing Du, et al.. (2019). Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA. Cancer Cell International. 19(1). 36 indexed citations
16.
Liu, Debin, et al.. (2018). Cardioprotection activity and mechanism of Astragalus polysaccharide in vivo and in vitro. International Journal of Biological Macromolecules. 111. 947–952. 44 indexed citations
18.
Yu, Lin, Xin Liu, Kang Cui, et al.. (2015). SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis. Cancer Research. 75(7). 1275–1286. 83 indexed citations
19.
Cui, Kang, et al.. (2013). Association of the G403A polymorphism in the RANTES gene with coronary artery disease: a meta-analysis. Genetics and Molecular Research. 12(3). 3912–3918. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026